BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sturgeon C. Standardization of tumor markers – priorities identified through external quality assessment. Scandinavian Journal of Clinical and Laboratory Investigation 2016;76:S94-9. [DOI: 10.1080/00365513.2016.1210334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Pan Q, Law COK, Yung MMH, Han KC, Pon YL, Lau TCK. Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity. PLoS One 2018;13:e0198980. [PMID: 30303958 DOI: 10.1371/journal.pone.0198980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Delanghe JR, De Buyzere ML. Twenty years of European IVD regulations and its aimed traceability - where are we? Clinica Chimica Acta 2018;483:263-4. [DOI: 10.1016/j.cca.2018.05.014] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ferraro S, Bussetti M, Rizzardi S, Braga F, Panteghini M. Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions. Clin Chem 2021;67:543-53. [PMID: 33674839 DOI: 10.1093/clinchem/hvaa268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ferraro S, Bussetti M, Panteghini M. Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice. Clin Chem 2021;67:602-9. [PMID: 33619518 DOI: 10.1093/clinchem/hvab002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nazari M, Gargari SLM, Sahebghadam Lotfi A, Rassaee MJ, Taheri RA. Aptamer-Based Sandwich Assay for Measurement of Thymidine Kinase 1 in Serum of Cancerous Patients. Biochemistry 2019;58:2373-83. [PMID: 30900869 DOI: 10.1021/acs.biochem.8b01284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ferraro S, Trevisiol C, Gion M, Panteghini M. Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice. Clinical Chemistry 2018;64:270-8. [DOI: 10.1373/clinchem.2017.275263] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
7 McMahon LM, Stewart WW, Cuthill L. Human chorionic gonadotrophin assays to monitor GTD. Best Pract Res Clin Obstet Gynaecol 2021;74:109-21. [PMID: 34074603 DOI: 10.1016/j.bpobgyn.2021.05.001] [Reference Citation Analysis]
8 Park J, Lee S, Kim Y, Choi A, Lee H, Lim J, Kim Y, Han K, Oh EJ. Comparison of Four Automated Carcinoembryonic Antigen Immunoassays: ADVIA Centaur XP, ARCHITECT I2000sr, Elecsys E170, and Unicel Dxi800. Ann Lab Med 2018;38:355-61. [PMID: 29611386 DOI: 10.3343/alm.2018.38.4.355] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ferraro S, Panzeri A, Braga F, Panteghini M. Serum α-fetoprotein in pediatric oncology: not a children’s tale. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:783-97. [DOI: 10.1515/cclm-2018-0803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]